Avi Daniel Conn's most recent trade in Tvardi Therapeutics Inc. was a trade of 45,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics Inc | Avi Daniel Conn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 45,000 | 45,000 | - | - | Employee Stock Option (right to buy) | |
| Tvardi Therapeutics Inc | Avi Daniel Conn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2025 | 17,500 | 17,500 | - | - | Employee Stock Option (right to buy) | |
| Tvardi Therapeutics Inc | Avi Daniel Conn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 43,547 | 43,547 | - | - | Employee Stock Option (right to buy) | |
| Tvardi Therapeutics Inc | Avi Daniel Conn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 89,053 | 89,053 | - | - | Employee Stock Option (right to buy) |